HBI Deals+Insights / Business Models and Strategy
We talk to a medtech outfit whose portable peritoneal dialysis device has been granted 'breakthrough' status in the US, and which could disrupt the big players in this market - and a seasoned operator who is less optimistic about the ability of tech like it to encourage higher uptake of peritoneal dialysis, the generally cheaper of the two treatments for end-stage renal disease.